| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |